A rock and a hard place: HPV testing and financial gain

被引:12
作者
Moriarty, Ann T. [1 ]
机构
[1] AmeriPath Indiana, Indianapolis, IN 46219 USA
关键词
D O I
10.1002/dc.20674
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
引用
收藏
页码:463 / 464
页数:2
相关论文
共 5 条
[1]  
*ALTS GROUP, 2003, AM J OBSTET GYNECOL, P1383
[2]   Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing? [J].
Liman, AK ;
Giampoli, EJ ;
Bonfiglio, TA .
CANCER CYTOPATHOLOGY, 2005, 105 (06) :457-460
[3]   Baseline cytology, human papillomavirus testing, and risk for cervical neoplasia: A 10-year cohort analysis [J].
Sherman, ME ;
Lorincz, AT ;
Scott, DR ;
Wacholder, S ;
Castle, PE ;
Glass, AG ;
Mielzynska-Lohnas, I ;
Rush, BB ;
Schiffman, M .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (01) :46-52
[4]   2001 consensus guidelines for the management of women with cervical cytological abnormalities [J].
Wright, TC ;
Cox, JT ;
Massad, LS ;
Twiggs, LB ;
Wilkinson, EJ .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2002, 287 (16) :2120-2129
[5]   Interim guidance for the use of human papillomavirus DNA testing as an adjunct to cervical cytology for screening [J].
Wright, TC ;
Schiffman, M ;
Solomon, D ;
Cox, JT ;
Garcia, F ;
Goldie, S ;
Hatch, K ;
Noller, KL ;
Roach, N ;
Runowicz, C ;
Saslow, D .
OBSTETRICS AND GYNECOLOGY, 2004, 103 (02) :304-309